260 related articles for article (PubMed ID: 33181239)
1. Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender.
Müller WE; Sillani G; Schuwald A; Friedland K
Neurochem Int; 2021 Feb; 143():104899. PubMed ID: 33181239
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties.
Friedland K; Silani G; Schuwald A; Stockburger C; Koch E; Nöldner M; Müller WE
Pharmacopsychiatry; 2021 Jan; 54(1):37-46. PubMed ID: 33254260
[TBL] [Abstract][Full Text] [Related]
3. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
Woelk H; Schläfke S
Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
[TBL] [Abstract][Full Text] [Related]
4. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels.
Schuwald AM; Nöldner M; Wilmes T; Klugbauer N; Leuner K; Müller WE
PLoS One; 2013; 8(4):e59998. PubMed ID: 23637742
[TBL] [Abstract][Full Text] [Related]
5. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Dienel A; Schläfke S
Int Clin Psychopharmacol; 2010 Sep; 25(5):277-87. PubMed ID: 20512042
[TBL] [Abstract][Full Text] [Related]
6. An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.
Kasper S
Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():15-22. PubMed ID: 23808618
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect.
Seifritz E; Schläfke S; Holsboer-Trachsler E
J Psychiatr Res; 2019 Aug; 115():69-74. PubMed ID: 31121394
[TBL] [Abstract][Full Text] [Related]
8. Silexan, an essential oil from flowers of Lavandula angustifolia, is not recognized as benzodiazepine-like in rats trained to discriminate a diazepam cue.
Silenieks LB; Koch E; Higgins GA
Phytomedicine; 2013 Jan; 20(2):172-7. PubMed ID: 23207249
[TBL] [Abstract][Full Text] [Related]
9. Effect of anxiolytic drug silexan on sleep - a narrative review.
Seifritz E; Kasper S; Möller HJ; Volz HP; Müller WE; Eckert A; Hatzinger M
World J Biol Psychiatry; 2022 Sep; 23(7):493-500. PubMed ID: 36259937
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial.
Kasper S; Volz HP; Dienel A; Schläfke S
Eur Neuropsychopharmacol; 2016 Feb; 26(2):331-340. PubMed ID: 26718792
[TBL] [Abstract][Full Text] [Related]
11. No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial.
Seifritz E; Möller HJ; Volz HP; Müller WE; Hopyan T; Wacker A; Schläfke S; Kasper S
Int J Neuropsychopharmacol; 2021 Mar; 24(3):171-180. PubMed ID: 33300578
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
Bartova L; Dold M; Volz HP; Seifritz E; Möller HJ; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):51-63. PubMed ID: 35262795
[TBL] [Abstract][Full Text] [Related]
13. Characterization of anxiolytic and neuropharmacological activities of Silexan.
Kumar V
Wien Med Wochenschr; 2013 Feb; 163(3-4):89-94. PubMed ID: 23361848
[TBL] [Abstract][Full Text] [Related]
14. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.
Baldinger P; Höflich AS; Mitterhauser M; Hahn A; Rami-Mark C; Spies M; Wadsak W; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522403
[TBL] [Abstract][Full Text] [Related]
15. Silexan in anxiety disorders: Clinical data and pharmacological background.
Kasper S; Müller WE; Volz HP; Möller HJ; Koch E; Dienel A
World J Biol Psychiatry; 2018 Sep; 19(6):412-420. PubMed ID: 28511598
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
Dold M; Bartova L; Volz HP; Seifritz E; Möller HJ; Schläfke S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1615-1628. PubMed ID: 36717399
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.
Möller HJ; Volz HP; Dienel A; Schläfke S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):183-193. PubMed ID: 29150713
[TBL] [Abstract][Full Text] [Related]
18. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A
Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of the Anxiolytic-Like Effects of Essential Oils in Animal Models.
de Sousa DP; de Almeida Soares Hocayen P; Andrade LN; Andreatini R
Molecules; 2015 Oct; 20(10):18620-60. PubMed ID: 26473822
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Silexan oral lavender essential oil compared to inhaled lavender essential oil aromatherapy for sleep in adults: a systematic review.
Greenberg MJ; Slyer JT
JBI Database System Rev Implement Rep; 2018 Nov; 16(11):2109-2117. PubMed ID: 30439747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
